| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.40B | +2.9% |
| Cost of Revenue | $9.17B | -3.7% |
| R&D Expense | $1.47B | +5.1% |
| SG&A Expense | $3.49B | +9.3% |
| Interest Expense | $180.0M | -22.7% |
| Pre-tax Income | $1.69B | +32.4% |
| Income Tax | $484.0M | +17.5% |
| Net Income | $1.09B | +20.6% |
| EPS (Basic) | $1.60 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.52B | +45.6% |
| Short-term Investments | $9.0M | -85.7% |
| Accounts Receivable | $4.88B | +9.7% |
| Inventory | $5.67B | +4.3% |
| Current Assets | $17.34B | +14.8% |
| Total Assets | $42.84B | +4.9% |
| Current Liabilities | $12.13B | +16.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.41B | +58.8% |
| Investing Cash Flow | -$543.0M | +7.8% |
| Financing Cash Flow | -$1.64B | -37.1% |
| +22.1% |
| EPS (Diluted) | $1.60 | +23.1% |
| Long-term Debt |
| $1.69B |
| -13.7% |
| Stockholders' Equity | $24.14B | +1.5% |